The Europe Actinic Keratosis Treatment Market would witness market growth of 4.1% CAGR during the forecast period (2022-2028).
A multitude of factors is taken into account when developing a treatment strategy for AK. These include characteristics and symptoms of AK, the patient's expectations, and the availability of treatments, the patient's capacity to adhere to treatment regimens, the tolerability of side effects, and the cost of treatments.
When lesions are many, bleeding, painful, and/or expanding quickly in size, it is a sign of urgency. Utilizing specialized tools to scrape away and burn (electrodessicate) the AK base is known as electrodesication and curettage. This procedure is repeated multiple times to get rid of all the AK and create clear margins. There are several possible topical alternatives like drugs and topically applicable creams or gels.
Applying a lotion or gel to the exposed lesions is known as a topical treatment. If there are multiple AKs in one region, this strategy might be employed. The drug causes a skin reaction that kills the AKs after being applied for a predetermined period of time. Topical medications typically cause the skin to become red, although they are quite powerful. Several research studies on less abrasive topical therapies for actinic keratosis are being conducted as well.
The expansion of AK treatments in this region is fueled by the rising number of actinic keratosis instances that have been documented and rising medical tourism. Due to the high incidence of actinic keratosis and the rising popularity of minimally invasive procedures, the demand has significantly grown in the United Kingdom. The affordable actinic keratosis treatment as well as advantageous Medicaid and Medicare reimbursements also impact the preference for AK treatment.
The Germany market dominated the Europe Actinic Keratosis Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $527.3 Million by 2028.The UK market is experiencing a CAGR of 3.3% during (2022 - 2028). Additionally, The France market would experience a CAGR of 4.9% during (2022 - 2028).
Based on Drug Class, the market is segmented into Nucleoside Metabolic Inhibitor, NSAIDs, Immune Response Modifiers, Photoenhancers and Others. Based on Therapy, the market is segmented into Surgery, Topical and Photodynamic Therapy. Based on End-use, the market is segmented into Hospitals, Private Clinics, Homecare and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Actinic Keratosis Treatment Market will Hit $8 Billion by 2028, at a CAGR of 4.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Almirall, S.A, LEO Pharma A/S, Biofrontera AG, Sun Pharmaceuticals Industries Ltd., 3M Company, Bausch Health Companies, Inc., Novartis AG, Viatris, Inc., and Galderma S.A.
Scope of the Study
Market Segments Covered in the Report:
By Drug Class
- Nucleoside Metabolic Inhibitor
- NSAIDs
- Immune Response Modifiers
- Photoenhancers
- Others
By Therapy
- Surgery
- Topical
- Photodynamic Therapy
By End-use
- Hospitals
- Private Clinics
- Homecare
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Almirall, S.A
- LEO Pharma A/S
- Biofrontera AG
- Sun Pharmaceuticals Industries Ltd.
- 3M Company
- Bausch Health Companies, Inc.
- Novartis AG
- Viatris, Inc.
- Galderma S.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Actinic Keratosis Treatment Market, by Drug Class
1.4.2 Europe Actinic Keratosis Treatment Market, by Therapy
1.4.3 Europe Actinic Keratosis Treatment Market, by End-use
1.4.4 Europe Actinic Keratosis Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Actinic Keratosis Treatment Market by Drug Class
3.1 Europe Nucleoside Metabolic Inhibitor Market by Country
3.2 Europe NSAIDs Market by Country
3.3 Europe Immune Response Modifiers Market by Country
3.4 Europe Photoenhancers Market by Country
3.5 Europe Others Market by Country
Chapter 4. Europe Actinic Keratosis Treatment Market by Therapy
4.1 Europe Surgery Market by Country
4.2 Europe Topical Market by Country
4.3 Europe Photodynamic Therapy Market by Country
Chapter 5. Europe Actinic Keratosis Treatment Market by End-use
5.1 Europe Hospitals Market by Country
5.2 Europe Private Clinics Market by Country
5.3 Europe Homecare Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Actinic Keratosis Treatment Market by Country
6.1 Germany Actinic Keratosis Treatment Market
6.1.1 Germany Actinic Keratosis Treatment Market by Drug Class
6.1.2 Germany Actinic Keratosis Treatment Market by Therapy
6.1.3 Germany Actinic Keratosis Treatment Market by End-use
6.2 UK Actinic Keratosis Treatment Market
6.2.1 UK Actinic Keratosis Treatment Market by Drug Class
6.2.2 UK Actinic Keratosis Treatment Market by Therapy
6.2.3 UK Actinic Keratosis Treatment Market by End-use
6.3 France Actinic Keratosis Treatment Market
6.3.1 France Actinic Keratosis Treatment Market by Drug Class
6.3.2 France Actinic Keratosis Treatment Market by Therapy
6.3.3 France Actinic Keratosis Treatment Market by End-use
6.4 Russia Actinic Keratosis Treatment Market
6.4.1 Russia Actinic Keratosis Treatment Market by Drug Class
6.4.2 Russia Actinic Keratosis Treatment Market by Therapy
6.4.3 Russia Actinic Keratosis Treatment Market by End-use
6.5 Spain Actinic Keratosis Treatment Market
6.5.1 Spain Actinic Keratosis Treatment Market by Drug Class
6.5.2 Spain Actinic Keratosis Treatment Market by Therapy
6.5.3 Spain Actinic Keratosis Treatment Market by End-use
6.6 Italy Actinic Keratosis Treatment Market
6.6.1 Italy Actinic Keratosis Treatment Market by Drug Class
6.6.2 Italy Actinic Keratosis Treatment Market by Therapy
6.6.3 Italy Actinic Keratosis Treatment Market by End-use
6.7 Rest of Europe Actinic Keratosis Treatment Market
6.7.1 Rest of Europe Actinic Keratosis Treatment Market by Drug Class
6.7.2 Rest of Europe Actinic Keratosis Treatment Market by Therapy
6.7.3 Rest of Europe Actinic Keratosis Treatment Market by End-use
Chapter 7. Company Profiles
7.1 Almirall, S.A
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 LEO Pharma A/S
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.3 Biofrontera AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Research & Development Expenses
7.4 Sun Pharmaceuticals Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 3M Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Bausch Health Companies, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Novartis AG
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Viatris, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Galderma S.A.
7.9.1 Company Overview
TABLE 1 Europe Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 2 Europe Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 3 Europe Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 4 Europe Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 5 Europe Nucleoside Metabolic Inhibitor Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Nucleoside Metabolic Inhibitor Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe NSAIDs Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe NSAIDs Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Immune Response Modifiers Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Immune Response Modifiers Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Photoenhancers Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Photoenhancers Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 16 Europe Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 17 Europe Surgery Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Surgery Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Topical Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Topical Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Photodynamic Therapy Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Photodynamic Therapy Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 24 Europe Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 25 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Private Clinics Market by Country, 2018 - 2021, USD Million
TABLE 28 Europe Private Clinics Market by Country, 2022 - 2028, USD Million
TABLE 29 Europe Homecare Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Homecare Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Actinic Keratosis Treatment Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Actinic Keratosis Treatment Market by Country, 2022 - 2028, USD Million
TABLE 35 Germany Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 36 Germany Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 37 Germany Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 38 Germany Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 39 Germany Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 40 Germany Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 41 Germany Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 42 Germany Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 43 UK Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 44 UK Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 45 UK Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 46 UK Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 47 UK Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 48 UK Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 49 UK Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 50 UK Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 51 France Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 52 France Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 53 France Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 54 France Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 55 France Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 56 France Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 57 France Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 58 France Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 59 Russia Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 60 Russia Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 61 Russia Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 62 Russia Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 63 Russia Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 64 Russia Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 65 Russia Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 66 Russia Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 67 Spain Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 68 Spain Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 69 Spain Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 70 Spain Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 71 Spain Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 72 Spain Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 73 Spain Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 74 Spain Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 75 Italy Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 76 Italy Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 77 Italy Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 78 Italy Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 79 Italy Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 80 Italy Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 81 Italy Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 82 Italy Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 83 Rest of Europe Actinic Keratosis Treatment Market, 2018 - 2021, USD Million
TABLE 84 Rest of Europe Actinic Keratosis Treatment Market, 2022 - 2028, USD Million
TABLE 85 Rest of Europe Actinic Keratosis Treatment Market by Drug Class, 2018 - 2021, USD Million
TABLE 86 Rest of Europe Actinic Keratosis Treatment Market by Drug Class, 2022 - 2028, USD Million
TABLE 87 Rest of Europe Actinic Keratosis Treatment Market by Therapy, 2018 - 2021, USD Million
TABLE 88 Rest of Europe Actinic Keratosis Treatment Market by Therapy, 2022 - 2028, USD Million
TABLE 89 Rest of Europe Actinic Keratosis Treatment Market by End-use, 2018 - 2021, USD Million
TABLE 90 Rest of Europe Actinic Keratosis Treatment Market by End-use, 2022 - 2028, USD Million
TABLE 91 Key Information – Almirall, S.A
TABLE 92 key information – LEO Pharma A/S
TABLE 93 Key Information – Biofrontera AG
TABLE 94 Key Information – Sun Pharmaceuticals Industries Ltd.
TABLE 95 Key Information – 3M Company
TABLE 96 key information – Bausch Health Companies, Inc.
TABLE 97 Key Information – Novartis AG
TABLE 98 key information – Viatris, Inc.
TABLE 99 Key Information – Galderma S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Almirall, S.A
FIG 3 SWOT Analysis: 3M Company